S. Carruthers

Determining the effectiveness of fibrin sealants in reducing complications in patients undergoing lateral neck dissection (DEFeND): study protocol for a randomised external pilot trial

R. Shaw, Catrin Tudur Smith, A. Schache, 2020, Pilot and Feasibility Studies.

Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.

A. Pettitt, C. Fegan, C. Yap, 2020, Haematologica.

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.

A. Pettitt, J. Radford, G. Follows, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA

A. Pettitt, R. Malladi, K. Ardeshna, 2019, Hematological Oncology.